Detection of Urinary Neopterin in Patients with Systemic Lupus Erythematosus and tis Clinical  Significance
	    		
		   		
	    	
    	
    	
   		
        
        	
        		- VernacularTitle:系统性红斑狼疮患者尿新喋呤水平检测及其临床意义
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Yuelan CHAO
			        		
			        		;
		        		
		        		
		        		
			        		Guojun SUN
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Lupus erythematosus;
			        		
			        		
			        		
				        		systemic Neopterin
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Dermatology
	            		
	            		 1995;0(03):-
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	The levels of urinary neopterin in 30 patients with SLE were determined by reversed-phase high performance liquid chromatgraphy(HPLC). The results showed: (1 ) the levels of urinary neopterin in 30 patients with SLE were significantly higher than those in 20 controls. (2) The concentrations of  urinary neopterin in SLE patients were significantly correlated with the disease activity, they decreased  after efficacious treatment with reduced disease activity. (3) There was significant positive correlation  between urinary neopterin concentration and erythrocyte sedimentation rate, but there were no statistical relations between urinary neopterin levels and ANA, antibody to ds-DNA, or plasma C3 levels. These results indicate that urinary neopterin may be used as an index for the assessment of disease activity in patients with SLE and monitoring  therapeutic effect.